-
Oct 22, 2024 | 
jdsupra.com | Megan Browdie |Sharon Connaughton |Jeremy Morrison
On October 10, 2024, the Federal Trade Commission (FTC) announced a unanimous 5-0 vote to finalize changes to the Hart-Scott-Rodino (HSR) premerger notification program, including changes to the HSR form and associated instructions, with the Department of Justice (DOJ) concurring with the final rule.
-
Sep 17, 2024 | 
jdsupra.com | Megan Browdie |David Wesley Burns |Sharon Connaughton
The US Department of Justice (DOJ) filed a complaint and proposed consent decree alleging that Legends Hospitality Parent Holdings prematurely acquired beneficial ownership – often referred to as “gun jumping” – in connection with its proposed acquisition of ASM Global.
-
Jan 25, 2024 | 
jdsupra.com | Megan Browdie |Sharon Connaughton |Howard Newcomb Morse
The Hart-Scott-Rodino (HSR) Act thresholds that govern which mergers & acquisitions must be reported to the US Department of Justice (DOJ) and Federal Trade Commission (FTC) will increase slightly more than 7% in February 2024. The key minimum “size-of-transaction” threshold will increase from $111.4 million to $119.5 million.
-
Nov 23, 2023 | 
mondaq.com | Howard Newcomb Morse |David Burns |Megan Browdie |Jonathan Davies
The US Federal Trade Commission (FTC) sent letters on November
7, 2023, accusing 10 companies of improperly listing drug delivery
device patents in the US Food and Drug Administration (FDA) Orange
Book, stating that the FTC has taken steps to "dispute"
these listings.
-
Nov 6, 2023 | 
concurrences.com | Howard Newcomb Morse |David Burns |Megan Browdie |Jonathan Davies
The US Federal Trade Commission (FTC) sent letters on November 7, 2023, accusing 10 companies of improperly listing drug delivery device patents in the US Food and Drug Administration (FDA) Orange Book, stating that the FTC has taken steps to “dispute” these listings. The FTC’s statements suggest the potential for future antitrust enforcement actions against these companies, as well as for further disputes regarding a “wide array of patent listings.”The FTC’s letters follow the agency’s Sept...
-
Nov 6, 2023 | 
concurrences.com | Howard Newcomb Morse |David Burns |Megan Browdie |Jonathan Davies
Previous article Next article Share on | The US Federal Trade Commission (FTC) sent letters on November 7, 2023, accusing 10 companies of improperly listing drug delivery device patents in the US Food and Drug Administration (FDA) Orange Book, stating that the FTC has taken steps to “dispute” these listings.
-
Sep 13, 2023 | 
jdsupra.com | Dee Bansal |Megan Browdie |Ethan Glass
In the wake of major bank failures in the US, the Department of Justice (DOJ) has signaled that it plans to step up antitrust enforcement of bank mergers. In June 2023, the DOJ’s Assistant Attorney General for Antitrust Jonathan Kanter delivered a speech at the Brookings Institution, providing listeners with insights into significant changes in the way the DOJ and bank regulators are reviewing proposed bank mergers.
-
Aug 8, 2023 | 
jdsupra.com | Megan Browdie |Caroline Hobson |Jonas Koponen
The Foreign Subsidies Regulation (FSR), the European Union’s new screening tool for third-country subsidies, introduces a novel and additional layer of scrutiny in public procurement. Companies that take part in sizeable public tenders in EU Member States need to account for the provision of significant information and the involvement of potentially time-consuming review processes in their bid strategy.
-
Aug 2, 2023 | 
jdsupra.com | Megan Browdie |Caroline Hobson |Jonas Koponen
The European Union’s new screening tool for third-country subsidies introduces a novel form of mergers & acquisitions scrutiny. Companies worldwide need to account for timing and execution risks arising from this system when M&A deals involve businesses with activities in the EU.
-
Jul 27, 2023 | 
mondaq.com | Megan Browdie |Jacqueline Grise |Howard Newcomb Morse |Kathleen O'Neill
On July 19, 2023, the US Department of Justice and Federal Trade
Commission released draft revised merger
guidelines in an effort to support the Biden
administration's aggressive antitrust enforcement agenda.
The draft guidelines, which are subject to public comment for 60
days, spell out novel theories of harm that the Biden DOJ and FTC
have pursued in recent enforcement actions and speeches.
